Close Icon We use cookies to improve your website experience. To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy. By continuing to use the website, you consent to our use of cookies.

Pharma Intelligence is part of the Informa Intelligence Division of Informa PLC

This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Products:

Pharma Consulting

Conferences 2021

Awards

Upcoming Webinars

Webinar recordings

Close Icon

Global Search Configuration

Search Site Products & Services
Close Icon

Search by Keyword

Focus
Needs

Medtech Market Intelligence

To succeed in medtech, you need to have your finger on the pulse – but accurate, reliable information is not always easy to find. We can help you get what you need.

Accurate expert analysis for a fragmented market

timely news deep insight pharma intelligence

Fast growth in the medical technology market is driven by innovation, demographic shifts, cost-efficient development and increased M&A activity. Success in this arena depends on your ability to bring cutting-edge solutions to the fore quickly, and having accurate intelligence is crucial for a sound development strategy.

How we help

Our medtech market intelligence will keep you up-to-date with important events and help you anticipate future technology needs – so you can evaluate new market opportunities and make confident business decisions.

Find comprehensive and accurate information on devices/diagnostics that compete in your markets
Stay abreast of important current events in our space that will affect your business
Rapidly find information on opportunities or targets within the medtech arena
Stay up to date with new trends and innovation in order to evaluate opportunities as they arise

See how we can help you get ahead in the competitive medtech environment: watch the video

Relevant products

Medtech Insight: global medical technology news & analysis

You’ll instantly connect to the latest in global medtech developments with industry news, trends, deals, product developments, opinions, analysis, and context behind the headlines and more – all available at your fingertips.

Key benefits:

Real-time news and analysis
Regulatory development news
Company development news

Meddevicetracker: medical device intelligence and forecasts

In the continually evolving medtech competitive landscape, it is vital to stay up-to-date with key events. With Meddevicetracker, you’ll be able to anticipate upcoming filings, research clinical trial dates and data, and access market size information and expert forecasts, all in one place.

Key benefits:

Real-time market intelligence
Medical device market coverage
Discover new opportunities

In Vivo: strategic insights for life sciences decision-makers

In Vivo offers comprehensive coverage of the global medical industry’s competitive landscape.

Key benefits:

Cutting edge thought leadership
Expert analysis
Hear from news makers

View all content

Medtech Insight

US Administrations and Medtech Industry: An International Focus

As the US embarks on a new era in leadership, changes in regulatory, policy, manufacturing and supply chains of medical devices and diagnostics will take place. What changes in the US medtech market can we expect to see over the next four years?

Topic Medtech

Single report
Medtech Insight

US Elections and Medtech Industry US focus

As the US embarks on a new era in leadership, changes in regulatory, policy, manufacturing and supply chains of medical devices and diagnostics will take place. What changes in the medtech market can we expect to see over the next four years?

Topic Medtech

Single report
Datamonitor Healthcare, Pink Sheet, Scrip, Medtech Insight, ...

Pharma Intelligence Podcasts

Listen to the Pharma Intelligence podcasts on Spotify, Apple Podcasts, Soundcloud and Alexa

Topic Coronavirus Manufacturing Market Intelligence Clinical Trials Blog Clinical Trials Drug Pricing

Full podcast
Medtech Insight

UK All-Party Report Assesses Brexit Medtech Impact While Germany Worries Over Border Delays

Government and industry in the UK are determined to make the best of the Brexit free trade deal, but German medtechs are eager for trade flow practicalities to be prioritized.

Topic Brexit Medtech-Brexit

View article
In Vivo

The Times They Are A-Changin’: Opportunities In Medtech Regulation For The UK After Brexit

The turn of the year is a chance to reflect on times past and the future, to make resolutions and look ahead to changes for the better. With Brexit in mind, this is the time to prophesize on UK medtech’s immediate future.

Topic Regulation Market Access Medtech-Brexit

View article
In Vivo

Pharma Intelligence Insights – Outlook 2021 Report

Power your strongest strategy for the year ahead with insights from the Outlook 2021 report. A combination of Scrip’s Scrip 100, Medtech Insight’s Medtech 100, and In Vivo’s Outlook reports, Outlook 2021 is a comprehensive window into the key trends, challenges and opportunities impacting the biopharma, medtech, and generics sectors for the year to come.

Topic Outlook

Single report
Medtech Insight

MedTech Summit 2020

The annual Medtech Summit was held online in 2020, and Medtech Insight was there, reporting on the presentations from more than 100 top medical device, diagnostic, and combination product speakers and 15+ Competent Authority and Notified Body representatives. In all, over 50 hours of live and on-demand sessions with critical information and guidance were presented.

Topic Medtech

Single report
Medtech Insight

MedTech Summit 2020

The annual Medtech Summit was held online in 2020, and Medtech Insight was there, reporting on the presentations from more than 100 top medical device, diagnostic, and combination product speakers and 15+ Competent Authority and Notified Body representatives. In all, over 50 hours of live and on-demand sessions with critical information and guidance were presented.

Topic Medtech

Single report
Medtech Insight

MedTech Summit 2020

The annual Medtech Summit was held online in 2020, and Medtech Insight was there, reporting on the presentations from more than 100 top medical device, diagnostic, and combination product speakers and 15+ Competent Authority and Notified Body representatives. In all, over 50 hours of live and on-demand sessions with critical information and guidance were presented.

Topic Medtech

Single report
Medtech Insight, Meddevicetracker

Meddevicetracker & Medtech Insight Spinal Device Markets

Discover what’s on the horizon for spinal devices and technology with news, analysis, and data from Medtech Insight and Meddevicetracker. Keep up with the latest developments from the annual NASS meeting and explore extracts from two data-packed recent reports: Spinal Fusion Implanted Instrumentation and Spinal Motion Preservation Devices Market.

Single report
Medtech Insight

10 Predictions On How Health Policy Could Change Under A Biden Presidency

Health policy changes that President-elect Joe Biden will likely make during his four-year term include Medicaid expansion and a greater reliance on medical science, among others, experts say.

Topic US Election 2020 Leadership Policy & Regulation

View article
In Vivo

How To Obtain Effective Relief When A Global Pandemic Disrupts Your Supply Chain

The COVID-19 pandemic is disrupting global supply chains and companies need effective tools to manage the related contract disputes. Sidley Austin partner Dorothee Schramm and senior associate Katie von der Weid, both specialized in international commercial disputes, provide tips to help companies manage the situation.

Topic Coronavirus Business Strategies Deals

View article
In Vivo

How To Negotiate With Public Payers: Five Lessons - And A Few Cautions - From The UK's New Pact On Drug Price And Access

In today’s globalized market for medicines, national rules on pricing and access are abundantly shared and more transparent than opaque. In Vivo speaks to the UK branded industry’s negotiator for the latest five-year joint pricing pact with the government, Richard Torbett, who outlines, among other topics, five widely applicable precedents from the talks that can work in “getting to yes” – despite the fractious budgetary climate for health care evident in all major country markets.

Topic Brexit Policy & Regulation

View article
Medtech Insight

Guidance FDA Will Look Other Way If Manufacturers Modify Imaging Systems To Fight COVID19

The US agency has relaxed its enforcement policy for X-ray, ultrasound and magnetic resonance imaging systems, as well as software for analyzing images, as US health care workers fight the novel coronavirus.

Topic Coronavirus FDA

View article
In Vivo

From US To EU: Young Biotechs Going It Alone

Europe’s patchwork of reimbursement agencies make it a daunting place for a small US biotech to do business. Traditionally large pharma partners or CMSOs have provided an experienced hand to hold, but as a new wave of gene therapies and orphan drugs get the EMA green light, smaller drug developers are applying innovation to commercialization and choosing to go solo.

Topic Market Access Rare Diseases Strategy

View analysis